ImmunityBio Reports Phase 3 Data Showing 84% Cystectomy Avoidance at Three Years and Complete Responses Beyond 53 Months with ANKTIVA® Plus BCG in BCG-Unresponsive NMIBC With CIS, With or Without Pap
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| (NASDAQ: IBRX) | Delayed: 8.08 -0.56 (6.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.64 | 52 Week High | $ | |||
| Open | $8.53 | 52 Week Low | $ | |||
| Day High | $8.84 | P/E | N/A | |||
| Day Low | $8.06 | EPS | $ | |||
| Volume | 7,309,136 | |||||
